- 3-12 months initial treatment
- Weeks to months for remission depending on histology
- 85%
China versus the U.S.
- China clinical rate
- $800 – $6,000
- $3,400
- United States
- $10,000 – $35,000
- $22,500
- You save
- ~85%
- $19,100 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Expert management of nephrotic syndrome including minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy at China's top nephrology departments. Treatment combines immunosuppressive therapy with supportive measures to reduce proteinuria and prevent complications. Access to newer biological agents and clinical trials for refractory cases.
Step by step.
Diagnostic Workup
24-hour proteinuria, serum albumin, lipid panel, and autoimmune serologies with kidney biopsy if indicated
Histological Classification
Expert renal pathology review to determine specific glomerular disease subtype
Immunosuppressive Therapy
Initiation of corticosteroids and/or steroid-sparing agents based on histological diagnosis
Response Monitoring & Adjustment
Regular proteinuria monitoring, complication prevention, and therapy modification based on response
- Expert glomerular disease specialists
- Access to rituximab and novel biologics at lower cost
- Integrated supportive care for edema and thrombosis prevention
- Clinical trial access for refractory cases
- Immunosuppression-related infections
- Steroid side effects with prolonged use
- Thromboembolic events
- Relapse requiring retreatment
Ask the AI for hospitals that handle nephrotic syndrome treatment.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.